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Abstract Aims To compare short- and long-term mor-
tality after a ﬁrst acute myocardial infarction (AMI) in
patients with and without diabetes mellitus. Methods and
results A nationwide cohort of 2,018 diabetic and 19,547
nondiabetic patients with a ﬁrst hospitalized AMI in 1995
was identiﬁed through linkage of the national hospital
discharge register and the population register. Follow-up
for mortality lasted until the end of 2000. At 28 days and
5 years respectively, absolute mortality risks were 18 and
53% in diabetic men, 12 and 31% in nondiabetic men, 22
and 58% in diabetic women, and 19 and 42% in nondia-
betic women. Crude mortality was signiﬁcantly higher in
diabetic patients than in nondiabetic patients in both men
(28-day hazard ratio (HR) 1.55; 95% conﬁdence interval
(CI) 1.32–1.81, 5-year HR 2.01; 95% CI 1.84–2.21) and
women (28-day HR 1.19; 95% CI 1.03–1.37, 5-year HR
1.53; 95% CI 1.40–1.67). After multivariate adjustment,
risk differences became nonsigniﬁcant at 28 days, but
diabetes was still associated with a signiﬁcantly higher
long-term mortality in both men (28-day HR 1.16; 95% CI
0.99–1.36, 5-year HR 1.49; 95% CI 1.36–1.64) and women
(28-day HR 1.12; 95% CI 0.97–1.28, 5-year HR 1.39; 95%
CI 1.27–1.52). The interaction between diabetes mellitus
and gender did not reach signiﬁcance in the analyses.
Conclusion Our ﬁndings in an unselected cohort covering a
complete nation show a signiﬁcantly higher long-term
mortality after a ﬁrst acute myocardial infarction in dia-
betic patients. Yet, short-term mortality is not signiﬁcantly
higher in diabetic patients. Risks appear to be equally
elevated in men and women.
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Introduction
It is well established that patients with diabetes mellitus
(DM) have a higher short-term mortality after acute myo-
cardial infarction (AMI) than patients without DM. Several
recent studies have found that hospital, 28-day and 1-year
mortality after AMI was approximately 1.5–2 times higher
in diabetic patients [1–3]. As it is known that most patients
survive beyond this period, it is important to study the
difference in long-term survival after an AMI between
diabetic and nondiabetic patients as well. Survival after an
AMI may be particularly worsened beyond the poorer
prognosis already conferred by the presence of DM itself,
as diabetic patients with an AMI may experience more
severe coronary heart disease and more complications (left
ventricular dysfunction and heart failure, signiﬁcant ven-
tricular arrhythmias) than nondiabetic patients with an
AMI [2, 3]. There are relatively few recent studies that
address differences in long-term prognosis after an AMI
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lasting through the second half of the 1990s [4–8]. More-
over, data largely originate from clinical trials or single
centers [4, 5, 7]. These studies reported that DM is inde-
pendently associated with long-term mortality [4–8].
The aim of the present study was to compare short- and
long-term mortality after a ﬁrst hospitalized AMI in
patients with and without DM encompassing the entire
country by using data from linked national registers.
Methods
Design
The study methods, including enrollment of the study
population, have recently been described in detail [9]. In
brief, cases of ﬁrst hospitalized AMI in the Netherlands in
1995 were identiﬁed by linkage of the Dutch national
hospital discharge register and the Dutch population reg-
ister. Thus, the study included a total of 21,565 patients
hospitalized for a ﬁrst AMI in 1995. These patients had not
been previously hospitalized for AMI from 1991 to 1995.
Information about demographic characteristics, medical
history and hospital outcomes was obtained from the hos-
pital register and the population register. All general and
academic hospitals and most specialty hospitals participate
in the hospital register. For each hospital admission a new
record is created in the hospital register, including the
following information: date of birth, gender, numeric part
of postal code, hospital-speciﬁc patient identiﬁcation code,
type of hospital, admission date and principal and sec-
ondary diagnoses of the admission. The principal diagnosis
is determined at discharge and is in retrospect the main
reason for admission. The diagnoses are coded using the
ninth revision and clinical modiﬁcation of the International
Classiﬁcation of Diseases (ICD-9-CM) [10]. The popula-
tion register contains information on all registered persons
living in the Netherlands, including date of birth, gender,
current address, postal code, nationality, native country
(both of registered person and his/her parents), date of
death and date of emigration. Patients whose parents were
both born in the Netherlands were classiﬁed as native
Dutch. Patients were classiﬁed as having a history of car-
diovascular disease or having DM when cardiovascular
disease (ICD-9-CM [10] codes 390–459 and subcategories,
principal diagnoses) or DM (ICD-9-CM [10] code 250
and subcategories, principal and secondary diagnoses) was
registered during previous hospital admissions in
1991–1995 and in case of DM also during the index
admission in 1995. Data on mortality of the patients were
derived by linking their records with the population register
and the cause of death certiﬁcates. In the population
register, it is recorded when a registered person has died.
Linkage of the population register with the cause of death
certiﬁcates yielded information on primary causes of death.
Data analysis
Survival time was calculated as the time from the initial
AMI admission date in 1995 to the date of death from any
cause, or a patient was censored at the date of loss to
follow-up in the population register (4% of patients, e.g. in
case of emigration) or the end of study at December 31,
2000, whichever came ﬁrst. Crude short-term (28-day), 1-
year and long-term (5-year) mortality risks were computed
for diabetic and nondiabetic patients. Cox proportional
hazard analyses were used to examine the association
between DM and overall survival in men and women. DM
(yes/no) and other predictors, including age (continuous),
previous cardiovascular disease (yes/no) and ethnic origin
(native or non-native Dutch) were included in the models.
Furthermore, Cox proportional hazards models were used
to determine whether gender, age, previous cardiovascular
disease and ethnic origin were independently associated
with overall survival in patients with DM and patients
without DM. Interaction terms were included in the models
to assess the interaction of gender with DM, age with DM
and age with gender.
Results
The characteristics of the diabetic and nondiabetic patients
with a ﬁrst AMI are presented in Table 1. Most of the
diabetic patients were women (52%), whereas most of the
nondiabetic patients were men (69%). In both diabetic and
nondiabetic patients, women were older and had a longer
duration of hospital stay than men. Diabetic patients were
older and more likely to have previous cardiovascular
disease (excluding AMI) compared to nondiabetic patients.
During admission, 18% of the diabetic patients (men
16%, women 20%) and 13% of the nondiabetic patients
(men 11%, women 18%) died. In both diabetic and non-
diabetic patients, AMI was the most frequent cause of
death (during hospitalization 71 and 82%, respectively, and
during 5 years of follow-up 39 and 45%, respectively).
Table 2 shows the higher absolute short- and long-term
mortality risks for diabetic patients compared to nondia-
betic patients in men and women.
Crude short- and long-term mortality was signiﬁcantly
higher in diabetic patients than in nondiabetic patients in
both men (28-day hazard ratio (HR) 1.55; 95% conﬁdence
interval (CI) 1.32–1.81, 5-year HR 2.01; 95% CI 1.84–
2.21) and women (28-day HR 1.19; 95% CI 1.03–1.37,
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1235-year HR 1.53; 95% CI 1.40–1.67). When differences in
age and other covariates between diabetic and nondiabetic
patients were taken into account, risk differences became
nonsigniﬁcant at 28 days, but DM was still associated with
a signiﬁcantly higher long-term mortality in both men and
women (Table 3). The interaction between gender and DM
for 28-day, 1-year and 5-year mortality did not reach sig-
niﬁcance in the analyses, indicating that risks are equally
elevated among men and women.
In the multivariate analyses, gender differences in
mortality in nondiabetic patients varied over time with a
higher mortality in women at 28 days and a higher mor-
tality in men at 5 years (28-day HR 1.11; 95% CI
1.03–1.20, 5-year HR 0.93; 95% CI 0.88–0.98). Largely
comparable, yet not signiﬁcant, gender differences in
mortality were found in diabetic patients (28-day HR 1.09;
95% CI 0.89–1.34, 5-year HR 0.93; 95% CI 0.82–1.04).
Discussion
Our study provides nationwide estimates of the difference
in mortality after a ﬁrst hospitalized AMI between diabetic
and nondiabetic patients. Long-term mortality was signif-
icantly higher in diabetic patients than in nondiabetic
patients. Yet, there were no signiﬁcant differences in short-
term mortality. Risks appeared to be equally elevated in
men and women.
Some aspects of the study need to be addressed. In our
study, the presence of DM was merely based on information
Table 1 Characteristics of ﬁrst acute myocardial infarction patients with and without diabetes mellitus
Patients with diabetes mellitus Patients without diabetes mellitus
Men Women Men Women
Number of patients 969 1,049 13,494 6,053
Age at admission (years)
Mean (standard deviation) 68.7 (11.0) 73.2 (10.3) 64.0 (12.3) 71.6 (12.0)
Prior admission for CVD (%) 31.7 31.0 16.8 16.3
Type of hospital (%)
Academic 6.7 6.1 6.2 5.7
General 93.3 93.9 93.8 94.3
Length of stay (days)
Mean (standard deviation) 11.1 (8.5) 12.5 (11.8) 9.7 (7.4) 10.6 (9.7)
Median 10.0 10.0 9.0 9.0
P25–P75
a 7.0–13.0 6.0–16.0 6.0–12.0 6.0–13.0
Native ethnic origin (%) 87.0 88.0 90.0 90.0
CVD = cardiovascular disease, excluding acute myocardial infarction
a 25th and 75th percentile
Table 2 Short- and long-term mortality in patients with a ﬁrst hospitalized acute myocardial infarction (AMI) in the Netherlands in 1995
stratiﬁed by gender and presence of diabetes mellitus
Men Diabetic patients (n = 969) Non-diabetic patients (n = 13,494)
Deaths (n) Deaths (%) Deaths (n) Deaths (%)
At 28 days 170 17.5 (15.1–19.9) 1,555 11.5 (11.0–12.1)
At 1 year 289 29.8 (26.9–32.7) 2,316 17.2 (16.5–17.8)
At 5 years 516 53.3 (50.1–56.4) 4,116 30.5 (29.7–31.3)
Women Diabetic patients (n = 1,049) Non-diabetic patients (n = 6,053)
Deaths (n) Deaths (%) Deaths (n) Deaths (%)
At 28 days 235 22.4 (19.9–24.9) 1,152 19.0 (18.0–20.0)
At 1 year 368 35.1 (32.2–38.0) 1,626 26.9 (25.7–28.0)
At 5 years 611 58.2 (55.3–61.2) 2,538 41.9 (40.7–43.2)
Figures are numbers and percentages of deaths (95% conﬁdence intervals in brackets) based on actuarial life table method
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123from hospital admissions and on a retrospective period of
maximal 5 years. As a result, the estimate of the effect of
DM is likely an overestimate due to selection of the more
severe cases (those hospitalized with or due to DM), while a
fairly limited number of people with less severe stages of
DM (not requiring hospital care) will be diluted in the large
group of people who truly did not have DM.
In our study, we were able to jointly evaluate a number
of predictors of mortality using information from the
hospital register. However, we were unable to examine
the contribution of other predictors on our outcomes,
including other risk factors, comorbidity and treatment, as
registration in the hospital register is limited. Yet, this
does not invalidate the ﬁnding that DM is related to a
worse long-term prognosis in patients with a ﬁrst AMI, as
confounding is not an issue in descriptive (prognostic)
research [11]. However, if cofactors such as the presence
of poorly treated hypertension or dyslipidemia become the
focus of investigation, the lack of more detailed infor-
mation from the hospital register renders such analyses
impossible.
In our study, the percentage patients with a cardiovas-
cular history (other than AMI) was about 2 times higher in
diabetic patients than in nondiabetic patients. To be sure
that the worse prognosis of diabetic patients compared to
nondiabetic patients was real and not merely a reﬂection of
the difference in cardiovascular history, we repeated the
analyses in diabetic and nondiabetic patients without a
cardiovascular history. These analyses yielded similar
ﬁndings.
The present study involved hospitalized ﬁrst AMI
patients. Out-of-hospital deaths from ﬁrst AMI were not
included. A substantial and possibly selective mortality
with regard to DM might have preceded the baseline of our
study, e.g. if DM were more prone to out-of-hospital death
[2] then this may result in less clear differences over the
rest of the ﬁrst 28 days, because the early deaths were not
recorded. Therefore, the study population does not repre-
sent (the diabetes distribution of) all ﬁrst AMI patients in
the Netherlands, but speciﬁcally hospitalized ﬁrst AMI
patients, and results might differ from population-based
studies, which usually manage to include the out-of-hos-
pital deaths.
As data on patients without an AMI were not available,
we were not able to compare the effect of DM on mortality
in patients without an AMI with the effect in patients with
an AMI, i.e. whether survival after an AMI is particularly
worsened beyond the poorer prognosis already conferred
by the presence of DM itself.
The strength of our study lies in the validity of the regis-
triesandlinkagemethods,thelargesizeandlackofselection
of the cohort and the long duration of follow-up. Recently, it
was shown that 99% of the personal, admission and dis-
charge data and 84% of the principal diagnoses (validated
through medical record review by medical specialists) were
correctly registered in a random sample of all hospital
admissions registered in the hospital register [12]. Further-
more, over 97% of the uniquely linked hospital admissions
resulting from linkage of the hospital register with the pop-
ulation register were shown to be correctly linked [13].
Results from different studies regarding differences in
mortality between diabetic and nondiabetic patients are
conﬂicting. Consistent with our ﬁndings, it has been
reported that DM has no independent predictive value on
Table 3 Multivariate analysis of the association between diabetes mellitus and short- and long-term mortality in ﬁrst acute myocardial infarction
patients (n = 21,565) by gender and age
Age (years) Follow-up duration
28 days 1 year 5 years
Men \60 1.41 (0.79–2.53) 1.38 (0.86–2.23) 1.83 (1.34–2.51)
60–69 1.46 (1.02–2.08) 1.73 (1.31–2.28) 1.80 (1.46–2.21)
70–79 1.04 (0.80–1.36) 1.16 (0.94–1.42) 1.42 (1.23–1.65)
‡80 1.11 (0.82–1.50) 1.32 (1.04–1.66) 1.37 (1.14–1.65)
All ages 1.16 (0.99–1.36) 1.33 (1.17–1.50) 1.49 (1.36–1.64)
Women \60 2.06 (1.09–3.88) 2.16 (1.25–3.75) 2.13 (1.40–3.25)
60–69 1.38 (0.92–2.06) 1.65 (1.19–2.29) 1.99 (1.57–2.54)
70–79 0.94 (0.72–1.22) 1.12 (0.92–1.37) 1.38 (1.19–1.60)
‡80 1.15 (0.94–1.42) 1.18 (0.99–1.40) 1.25 (1.09–1.44)
All ages 1.12 (0.97–1.28) 1.23 (1.09–1.37) 1.39 (1.27–1.52)
Total All ages 1.13 (1.02–1.26) 1.27 (1.17–1.38) 1.44 (1.35–1.53)
Figures are hazard ratios (95% conﬁdence intervals in brackets) with nondiabetic patients representing the reference group
Results from Cox proportional hazards analyses with diabetes mellitus, previous cardiovascular disease and ethnic origin (age- and gender-
speciﬁc hazard ratios) and age (gender-speciﬁc overall hazard ratios) and gender (overall hazard ratios) included in the model
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123short-term mortality [14]. Yet, several other recent studies
showed that short-term (\1 year) mortality after AMI was
signiﬁcantly higher (approximately 1.5 to 2 times) in dia-
betic patients compared with nondiabetic patients [1–3,
15]. Weitzman et al. [16] found a signiﬁcant higher 1-year
mortality in diabetic men (odds ratio (OR) 1.5; 95% CI
1.2–1.9), but no signiﬁcant association in women. Recent
studies regarding differences in long-term mortality (fol-
low-up ranging from 4 to 10 years) after AMI showed an
approximately 1.5–2.5 higher risk of dying in diabetic
patients [4–8, 17]. Ishihara et al. [18] showed that DM was
an independent predictor of 10-year mortality in patients
with single vessel disease (OR 1.81; 95% CI 1.27–2.54),
but in patients with multivessel disease the inﬂuence of
DM was nonsigniﬁcant (OR 1.17; 95% CI 0.85–1.60).
Melchior et al. [5] reported that the difference in mortality
after AMI between diabetic and nondiabetic patients
increased with time (relative risk ranging from 1.03 [95%
CI 0.81–1.31] at 30 days to 1.43 [95% 1.24–1.66] at
2 months-3 years and 1.74 [95% CI 1.36–2.23] at 7–
9 years in patients admitted between 1990 and 1992).
We found no signiﬁcant differences in short- and long-
term mortality after a ﬁrst AMI between men and women
in diabetic patients. A few other studies examined gender
differences in mortality after an AMI in diabetic patients.
Crowley et al. [19] found that women with DM were at
increased risk of hospital death compared to men (OR 1.37;
95% CI 1.08–1.75), but no signiﬁcant gender difference in
1-year mortality (HR 1.25; 95% CI 0.99–1.58) and 10-year
mortality (hazard ratio 1.00; 95% 0.99–1.58) was found.
Two other studies showed a higher short-term (hospital or
28-day) mortality in women [2, 20].
The higher risk of long-term mortality in ﬁrst AMI
patients with DM reinforces the importance of vigorous
preventive measures by lifestyle advice and drugs in these
patients. Currently, achievement of lifestyle and risk factor
goals for reducing mortality in diabetic patients with AMI
is poor, as illustrated by Pyorala et al. [21] who reported
that 20% of diabetic patients continued to smoke, 43%
were obese, 57% had hypertension and 55% had hyper-
cholesterolemia at least 6 months after hospitalization for
coronary heart disease. A long-term, intensive approach
consisting of behavior modiﬁcation and pharmacologic
therapy aimed at multiple risk factors is necessary, as it has
been shown that this results in an impressive reduction in
cardiovascular complications in patients with DM [22].
In conclusion, our ﬁndings in an unselected cohort
covering a complete nation show that diabetic patients are
at an increased risk of long-term mortality after a ﬁrst acute
myocardial infarction. Yet, there are no signiﬁcant differ-
ences in short-term mortality. Risks appear to be equally
elevated in men and women. These results stress the
importance of secondary prevention by lifestyle advice and
drugs in diabetic patients after a ﬁrst AMI.
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